Publications

Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance After First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the Mcl R2 Elderly Clinical Trial

AuthID
P-00X-4CM

Author(s)

Ribrag, V

Safar, V

Kluin Nelemans, H

Oberic, L

Feugier, P

Casasnovas, O

Thieblemont, C

Daguindau, N

Damaj, GL

Klapper, W

[+4]·

da Silva, MG

Carcinero, F

Marin Niebla, A

Taszner, M

Walewski, J

Boersma, R

Houtenbos, I

Delfau Larue, MH

Le Gouill, S

Dreyling, MH

View all authors

Document Type

Abstract

Year published

2021

Published

in BLOOD, ISSN: 0006-4971

Volume: 138

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1182/blood-2021-149600

Wos: WOS:000736398801155

Source Identifiers

ISSN: 0006-4971

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Show entries

Search:

Name Order	Name	Name Order	Name	Name Order	Name
1	Ribrag, V;	2	Safar, V;	3	Kluin Nelemans, H;
4	Oberic, L;	5	Feugier, P;	6	Casasnovas, O;
7	Thieblemont, C;	8	Daguindau, N;	9	Damaj, GL;
10	Klapper, W;	11	Hoster, E;	12	von Weikersthal, LF;
13	Haenel, M;	14	Andre, M;	15	da Silva, MG;
16	Carcinero, F;	17	Marin Niebla, A;	18	Taszner, M;
19	Walewski, J;	20	Boersma, R;	21	Houtenbos, I;
22	Delfau Larue, MH;	23	Le Gouill, S;	24	Dreyling, MH;

Showing 1 to 8 of 8 entries

Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance After First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the Mcl R2 Elderly Clinical Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance After First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the Mcl R2 Elderly Clinical Trial

Useful Links

Get Help